跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
再普乐 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Olanzapine Tablets
Approved
化学药品
Olanzapine Tablets
Cheplapharm Registration GmbH
🇨🇳 National Medical Products Administration
Approval Date
May 20, 2020
Approval ID
7MazXbPZWXb
Company
Cheplapharm Registration GmbH
Type
化学药品
Approval Details
Approval Id
7MazXbPZWXb
Approval Number
H20160499
Generic Name
奥氮平片
Generic Name En
Olanzapine Tablets
Trade Name
再普乐
Drug Type
化学药品
Dosage Form
片剂
Strength
2.5mg
Reg Date
2020-05-20
Expired Date
2025-05-19
Company Name
Cheplapharm Registration GmbH
Company Address
Weiler Straße 5e, 79540 Lörrach, Germany
Production Company Name
LILLY SA
Production Company Address
Avda. de la Industria 30, 28108 Alcobendas, Madrid, Spain
Company Detail Path
/organization/cheplapharm-registration-gmbh
Production Company Detail Path
/organization/lilly-sa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 20, 2020
Approval ID
7MazXbPZWXb
Type
化学药品
Back to NMPA Approvals